Hsv Infection Model
Hsv Infection Model - Related Videos
02:48
Labeling of Replicating HSV-1 Genomes with a Nucleoside Analog
0 Views •
2026
Source: Dembowski, J. A., Deluca, N. A. Purification of Viral DNA for the Identification of Associated Viral and Cellular Proteins. J. Vis. Exp. (2017)This video demonstrates the infection of stationary-phase mammalian cells with HSV-1 (Herpes Simplex Virus-1), followed by replication of the viral genome using host and viral replication machinery. A synthetic nucleoside analog is incorporated into newly synthesized viral DNA to label replicating genomes, which are subsequently isolated for...
07:30
HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
0 Views •
Cited by 8 •
2016
This article describes how to inject viral vectors into the mouse frontal cortex to test behavioral assays that require GPCR heteromeric formation.
07:55
Ex Vivo Organotypic Corneal Model of Acute Epithelial Herpes Simplex Virus Type I Infection
0 Views •
Cited by 27 •
2012
In this video article we describe the use of a new ex vivo model of acute herpes simplex virus type I corneal epithelial infection.
12:30
Use of Galleria mellonella as a Model Organism to Study Legionella pneumophila Infection
0 Views •
Cited by 108 •
2013
The larva of the wax moth Galleria mellonella was recently established as an in vivo model to study Legionella pneumophila infection. Here, we demonstrate fundamental techniques to characterize the pathogenesis of Legionella in the larvae, including inoculation, measurement of bacterial virulence and replication as well as extraction and analysis of infected hemocytes.
12:33
Determination of Biofilm Initiation on Virus-infected Cells by Bacteria and Fungi
0 Views •
Cited by 3 •
2016
A method is described herein for the determination of inter-Kingdom association and competition (bacterial and fungal) for adherence to virus-infected HeLa cell monolayers. This protocol can be extended to multiple combinations of prokaryotes, eukaryotes, and viruses.
FAQs
An HSV infection model can capture two biologically distinct phases: productive infection and persistence. During productive infection, viral genome replication leads to production of new virions. In sensory-neuron models, the system can also represent latency, followed by reactivation under appropriate conditions. This distinction helps separate mechanisms of viral replication from those sustaining recurrent disease.
Sensory neurons provide the setting needed to study latency and reactivation, rather than only immediate viral replication. Their inclusion allows investigators to examine how HSV persists after an initial infection and how the virus can return to a productive state. This makes neuronal systems particularly relevant to research on recurrent disease and long-term viral persistence.
By following infection in a controlled laboratory system, investigators can examine innate and adaptive immune responses alongside viral replication and tissue damage. This paired analysis helps relate host responses to viral replication, tissue damage, and persistence, giving immunology studies a framework for investigating how host defenses shape infection and how viral activity affects the host.
Cell culture systems allow researchers to investigate virus-host interactions in a laboratory setting, whereas animal models can reproduce infection-related features in a whole organism. Using both approaches helps link molecular findings to broader outcomes such as tissue damage, immune responses, persistence, and recurrent disease, strengthening interpretation across experimental levels.
Studies typically track the sequence from viral entry into susceptible cells through genome replication and production of new virions. Depending on the model, investigators may then examine establishment of latency in sensory neurons and reactivation under appropriate conditions. Measuring these stages provides a structured way to relate viral behavior to host responses and disease-associated outcomes.
They provide experimental systems for assessing antiviral therapies, vaccines, and approaches intended to prevent transmission or control recurrent disease. Because the models can represent replication, persistence, immune responses, and tissue damage, investigators can examine whether an intervention affects viral production, longer-term infection, or disease-related consequences. The resulting evidence can connect molecular effects with clinical infection.
It lets researchers study immunity in the context of an active virus-host interaction rather than examining immune responses in isolation. The model supports analysis of innate and adaptive responses together with viral pathogenesis, tissue damage, and persistence. These linked observations help explain how infection develops and provide context for strategies aimed at controlling disease.